Critical Care Devices Market – By Product, By Application, By End Use – Global Forecast, 2025 to 2034

Critical Care Devices Market Size

The global critical care devices market size was valued at around USD 60.1 billion in 2024 and is estimated to grow at 5.5% CAGR from 2025 to 2034. Critical care devices are specialized medical equipment uses medical technology for the purposes of assisting and supervising patients in an array of difficult conditions, most often in the setting of intensive care units (ICUs).
 

Such life support equipment enables in the treatment of severe health disorders that need invariable monitoring alongside immediate and advanced healthcare interventions. Notable examples are ventilators for assisting respiration, infusion pumps for infusion of accurate doses of medication, patient monitors for observing vital parameters, Defibrillators that are expected to touch for heart emergencies, and dialysis machines for patients with kidney failure.
 

The increasing prevalence of chronic conditions such as cardiovascular disease, respiratory illnesses, and diabetes is leading to a higher demand for critical care interventions. Cardiovascular disease is the leading cause of death in the world according to World Health Organization (WHO) data, staggering 17.9 million people per year. The situation is worsened by acute conditions such as infections and trauma, which require the use of ventilators, defibrillators, infusion pumps and similar devices for better treatment.
 

According to the Centers of Disease Control and Prevention, every year 1.7 million adult citizens in the U.S. get sepsis, among whom at least 350 thousand die. The combined load of chronic and acute diseases is further fueling the demand for critical care devices across the globe.
 

In addition to that, the market is expected to benefit from the increase in the number of product introductions and business activities such as acquisitions, collaborations and regional expansions by the industry participants. For example, in September 2024 BD, a reported that it had acquired of the Critical Care product group of Edwards Lifesciences. This new unit further complemented BD's existing array of intelligent and connected care solutions that employ advanced monitoring methods. Such spending is said to stimulate the considerable expansion of the market by boosting innovation, widening the market for advanced monitoring devices, and increasing rivalry.

Critical Care Devices Market Trends

• The use of AI and machine learning is being incorporated into ventilators and other critical care devices, such as patient monitors and infusion pumps. The aim of this integration is to enhance predictive analysis and clinical decision making.
   
• These technologies facilitate constant monitoring of patients, fast tracking of any deteriorating conditions, and automation of device changes which improves the critical care response time and result.
   
• Moreover, remote patient monitoring and tele-ICU services have become more common after the outbreak of COVID-19, which created a stronger demand for remote critical care support in patients.
   
• This is especially important for areas with little or no access to health care services or fewer resources to run ICUs.
   

Critical Care Devices Market Analysis

Based on product, the market is segmented into defibrillators, multiparameter monitoring devices, ECG devices, hemodialysis machines, infusion pumps, ventilators, feeding tubes, anesthesia monitors, CRRT machines, and other products. The defibrillators segment dominated the market with the largest revenue share of 22.6% in 2024.
 

• The growing elderly population is prone to having cardiac disorders, as per estimates provided by the World Health Organization, it is suggested that between the years 2015 and 2050, the percentage of the global population that will be above 60 years will approximately reach between 12 to 22 percent.
   
• With the growing elderly global population, there has been rise in the demand for defibrillators in order to treat them alongside managing age-related heart conditions, more specifically in demographics that are rapidly becoming older, these shifts are anticipated to sharply increase the need for defibrillators from both clinics and the public on account of the increasing prevalence of cardiovascular diseases.
   
• Moreover, governments and other healthcare authorities are trying to put funds into the public access defibrillation (PAD) programs where they make use of automated external defibrillators (AEDs) and reach to the public using schools, airports and sports venues.
   
• Some countries have mandated the usage of AEDs in public spaces due to which more people are aware of the devices which tend to expand the market, this is especially seen in North America and Europe region where such devices are being installed in public areas alongside being part of the PAD programs.
   

Based on application, the critical care devices market is segmented into renal care, cardiology, neurology, and other applications. The cardiology segment dominated the market with the largest revenue share of 35.8% in 2024.
 

• It is estimated that CVDs such as heart attacks and cardiac failures are the leading cause of death all over the world as reported by the World Heart Federation, global deaths as a result of overextended CVD tripled from 12.1 million in 1990 to 20.5 million in 2021.
   
• The above mentioned statistics provide insight that there is strong demand for effective monitoring and life-support devices within emergency departments and ICU units.
   
• With technology evolving, patient comfort is becoming a priority, this contributed to the growing popularity of minimally invasive cardiac procedures, which has fueled the demand for advanced monitoring devices.
   
• Critical care cardiology equipment is always in demand as cardiac catheterization, ablation procedures along with electrophysiology studies require consistent monitoring.
   

Based on end use, the critical care devices market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and other end-users. The hospitals segment dominated the market with the largest revenue share of 43.3% in 2024.
 

• The efficiency and effectiveness of critical care are enhanced by healthcare technology innovations, such as advanced patient monitoring systems such as AI systems support and connected technologies.
   
• The technologies are increasingly being used by hospitals to provide timely information collection, analysis, and decision making which translates to better patient care and operational efficiency in ICUs.
   
• The COVID-19 pandemic also brought out a sharp rise in the need for critical care devices particularly the ventilators and oxygen therapy machinery owing to increasing hospitalization and complex respiratory ailment cases.
   
• For example, the National Institutes of Health estimated that the occupancy rate of intensive care units was over 67.8 percent for the peak coronavirus infections. This surge in demand for the devices promoted the hospitals to install more specialized ICU equipment and led to an ongoing need for oxygen devices.
   

• The U.S. critical care devices market is projected to grow significantly, reaching USD 34.4 billion by 2034.
   
• It is anticipated that this development will contribute to the strengthening of the position of GE HealthCare in the U.S. market, characterized by the rising technological demand for advanced critical care technologies.
   
• Therefore, the ongoing investments and acquisitions should contribute to the further expansion of the US critical care device market in terms of improving the technology and the quality of care provided to the patients.
   

The critical care devices industry in UK is expected to experience significant and promising growth from 2025 to 2034.
 

• There is a growing demand for critical care devices within the UK as a result of increased cases of chronic illnesses such as cardiovascular, chronic respiratory diseases, and diabetes. For example, as reported by Diabetes UK, about 5.6 million people in the UK had diabetes in 2023.
   
• Moreover, the already increased need for ICUs alongside the hospitalization of elderly patients suggests that these individuals are generally more likely to develop the above-stated conditions.
   
• As a result of this shift in population structure, a higher need for critical care devices such as ventilators and patient monitoring equipment has arisen. Consequently, there is a rise in need, which is being met by an improvement in technology when it comes to critical care devices in the region.
   

Japan critical care devices market is anticipated to witness lucrative growth between 2025 – 2034.
 

• In 2023, according to WHO, Japanese women lead in life expectancy of 87.14 years, whilst men reach an average of 81.09 years. This has resulted in a high aging rate, with more than 29.1% of Japan’s citizens aged 65 or older by 2023 (BBC, 2023).
   
• This demographic shift is likely to continue to spur market development in Japan. Directly relevant is the increasing demand for critical monitoring and life-support systems spurred by chronic and critical health complications affecting elderly people, such as cardiovascular and respiratory complications and stroke.
   

The critical care devices industry in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.
 

• The rising prevalence of lifestyle-related diseases, including cardiovascular diseases, diabetes, and respiratory illnesses, has led to a higher demand for critical care devices.
   
• For example, more than 15% of people in Saudi Arabia suffer from acute lower respiratory tract infection every year, as put forth by the National Institutes of Health. This phenomenon has caused an increased demand for sophisticated monitoring devices, ventilators, and other life-support systems in healthcare institutions in the region.
   

Critical Care Devices Market Share

The market is competitive, with plenty of major and small companies joining the race along with the major global ones. One strategy that companies are utilizing is to focus on advancing technology in AI-enabled devices, remote patient monitoring, smart ventilators, and wearable patient monitors to improve efficiency and precision.
 

Strategic collaborations with research centers and medical institutions are vital to applying new technologies and broadening the distribution network, allowing the companies to meet the growing need for critical care telemetry. Government incentives and simplified procedures for the firms augment the competition and facilitate innovations, which assist the companies in reinforcing their influence in the growing market.
 

Critical Care Devices Market Companies

Some of the eminent market participants operating in the critical care devices industry include:

• Air Liquide Medical Systems India
• Asahi Kasei Corporation
• B. Braun Melsungen
• Baxter
• Becton, Dickinson and Company
• Boston Scientific corporation
• Cardinal Health
• Drägerwerk
• Fresenius Medical Care
• GE Healthcare
• Getinge
• Hamilton Medical
• ICU Medical
• Koninklijke Philips
• Medtronic
   

• Asahi Kasei Corporation is a leader in membrane technology for extracorporeal therapies, focusing on biocompatibility alongside optimized dialysis and blood purification, and offering exceptional critical care. In renal care as well as fluid administration.
   
• Baxter International Incorporated tops the list by employing monitoring technologies in real-time, which increases the accuracy of the intervention and efficiency of the operation in an intensive care facility.
   
• B. Braun Melsungen combines innovation, precision, and safety into a comprehensive offering that encompasses infusion systems alongside pain management and infection control devices for patients in ICUs.
   

Critical Care Devices Industry News:

• In September 2024, Medtronic launched the VitalFlow, an all-in-one extracorporeal membrane oxygenation (ECMO) system, designed to offer a user-friendly experience. The company aimed to create a simple and intuitive device that would assist clinicians by streamlining the ECMO process, making it easier to operate. This launch strengthened Medtronic's position in the critical care market by providing healthcare professionals with advanced, easy-to-use technology.
   
• In January 2022, ICU Medical Inc. announced the completion of its acquisition of Smiths Medical from Smiths Group plc. Smith’s Medical's business includes syringe and ambulatory infusion devices, vascular access, and vital care products. This acquisition strengthened ICU Medical’s portfolio, expanding its offerings in critical care and infusion therapy.
   

The critical care devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and volume in Units from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Defibrillators
• Multiparameter monitoring devices
• ECG devices
• Hemodialysis machines
• Infusion pumps
• Ventilators
• Feeding tubes
• Anesthesia monitors
• CRRT machines
• Other products

Market, By Application

• Renal care
• Cardiology
• Neurology
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Specialty clinics
• Other end users

The above information is provided for the following regions and countries:

• North America

• U.S.
• Canada

• Europe

• Germany
• UK
• France
• Italy
• Spain
• Poland
• Austria
• Denmark
• Switzerland
• Netherlands
• Czech Republic
• Sweden

• Asia Pacific

• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Indonesia
• Vietnam

• Latin America

• Brazil
• Mexico
• Argentina
• Colombia

• Middle East and Africa

• Saudi Arabia
• South Africa
• UAE
• Iran